| Name | Title | Contact Details |
|---|
At PopHealthCare, we believe healthcare should be personal. For us, that means bringing care to those who need it most, where they will be able to achieve their health goals best–at home or wherever they reside. Using in-home assessments and cutting-edge analytics, we identify high-risk patients and partner with health plans to keep them out of the hospital with our care team of compassionate, smart, deeply committed healthcare providers available 24/7. This commitment and integrity expands to all areas of our business. With over 22 clients in 17 states, PopHealthCare offers a fully integrated approach to care delivery, risk adjustment and quality enhancements, serving the highest risk populations with unwavering dedication. Our risk adjustment solutions include not only risk adjustment, but also chart retrievals and analytics and reporting, to help you effectively manage your risk adjustment program. Our goal is to facilitate risk score accuracy and help clients plan for the future with more precision, leveraging our unique combination of technology, in-depth industry expertise, and concierge-level service. Emcara Health, PopHealthCare`s value-based national medical group that does house calls for vulnerable populations, delivers personalized, attentive care either as the Primary Care Provider (PCP) or in collaboration with a patient`s community-based PCP. PopHealthcare`s success in spearheading the transformation of in-home care enables Emcara Health to deliver industry-leading outcomes in patient experience, care quality, cost of care, health equity, and employee satisfaction. As part of the GuideWell family of companies, we are working hard every day to improve the delivery of care through new innovative models that provide superior health outcomes for patients and our partners.
Geonetric is a Cedar Rapids, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.
Golden Heights Living Center is a Garnett, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Invatec is a Bethlehem, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.